310 related articles for article (PubMed ID: 19590505)
1. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
Matsuyama N; Tsutsumi T; Kubota N; Nakajima T; Suzuki H; Takeyama Y
Hypertens Res; 2009 Aug; 32(8):721-6. PubMed ID: 19590505
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
[TBL] [Abstract][Full Text] [Related]
3. Effects of angiotensin II on the action potential durations of atrial myocytes in hypertensive rats.
Sonoyama K; Igawa O; Miake J; Yamamoto Y; Sugihara S; Sasaki N; Shimoyama M; Hamada T; Taniguchi S; Yoshida A; Ogino K; Shigemasa C; Hoshikawa Y; Kurata Y; Shiota G; Narahashi T; Horiuchi M; Matsubara H; Ninomiya H; Hisatome I
Hypertens Res; 2005 Feb; 28(2):173-9. PubMed ID: 16025745
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of olmesartan and azelnidipine on atrial structural remodeling in spontaneously hypertensive rats.
Okamura K; Ito M; Tanaka K; Chinushi M; Adachi T; Mitsuma W; Hirono S; Nakazawa M; Kodama M; Aizawa Y
Pharmacology; 2009; 83(6):360-6. PubMed ID: 19440002
[TBL] [Abstract][Full Text] [Related]
5. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
6. Sympatho-inhibitory properties of various AT1 receptor antagonists.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens Suppl; 2002 Jun; 20(5):S3-11. PubMed ID: 12184061
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of angiotensin II type 1 receptor blocker at an advanced stage of hypertensive diastolic heart failure.
Nishio M; Sakata Y; Mano T; Yoshida J; Ohtani T; Takeda Y; Miwa T; Masuyama T; Yamamoto K; Hori M
J Hypertens; 2007 Feb; 25(2):455-61. PubMed ID: 17211254
[TBL] [Abstract][Full Text] [Related]
8. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
[TBL] [Abstract][Full Text] [Related]
9. Continuous inhibition of the renin-angiotensin system and protection from hypertensive end-organ damage by brief treatment with angiotensin II type 1 receptor blocker in stroke-prone spontaneously hypertensive rats.
Takemori K; Ishida H; Ito H
Life Sci; 2005 Sep; 77(18):2233-45. PubMed ID: 15963533
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
[TBL] [Abstract][Full Text] [Related]
11. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor.
Bian YL; Qi YX; Yan ZQ; Long DK; Shen BR; Jiang ZL
Eur J Cell Biol; 2008 Feb; 87(2):101-10. PubMed ID: 17963997
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Ang II and renal sympathetic nerve influence dopamine-and isoprenaline-induced renal haemodynamic changes in normal Wistar-Kyoto and spontaneously hypertensive rats.
Abdulla MH; Sattar MA; Abdullah NA; Hazim AI; Anand Swarup KR; Rathore HA; Khan MA; Johns EJ
Auton Autacoid Pharmacol; 2008 Oct; 28(4):95-101. PubMed ID: 18778332
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin-II (AT-II) receptor blocker olmesartan reduces renal damage in animal models of hypertension and diabetes.
Pugsley MK
Proc West Pharmacol Soc; 2005; 48():35-8. PubMed ID: 16416656
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats.
Rizzoni D; Pasini E; Flati V; Rodella LF; Paiardi S; Assanelli D; De Ciuceis C; Porteri E; Boari GE; Rezzani R; Speca S; Favero G; Martinotti S; Toniato E; Platto C; Agabiti-Rosei E
J Hypertens; 2008 Aug; 26(8):1595-601. PubMed ID: 18622238
[TBL] [Abstract][Full Text] [Related]
15. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR.
Lin Y; Matsumura K; Kagiyama S; Fukuhara M; Fujii K; Iida M
Brain Res; 2005 Oct; 1058(1-2):161-6. PubMed ID: 16143317
[TBL] [Abstract][Full Text] [Related]
17. Short-term treatment of stroke-prone spontaneously hypertensive rats with an AT1 receptor blocker protects against hypertensive end-organ damage by prolonged inhibition of the renin-angiotensin system.
Hamaguchi R; Takemori K; Inoue T; Masuno K; Ito H
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1151-5. PubMed ID: 18518883
[TBL] [Abstract][Full Text] [Related]
18. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade.
Igase M; Kohara K; Nagai T; Miki T; Ferrario CM
Hypertens Res; 2008 Mar; 31(3):553-9. PubMed ID: 18497476
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K
Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
